Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody
View ORCID ProfileFeng Yangchun
doi: https://doi.org/10.1101/2020.04.07.20053660
Feng Yangchun
The Clinical Laboratory Center, The Third Hospital Affliated to Xinjiang Medical University, 830011, Urumqi, China
Article usage
Posted April 08, 2020.
Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody
Feng Yangchun
medRxiv 2020.04.07.20053660; doi: https://doi.org/10.1101/2020.04.07.20053660
Subject Area
Subject Areas
- Addiction Medicine (351)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2667)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12282)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4132)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2681)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (856)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3922)
- Nursing (212)
- Nutrition (583)
- Oncology (2057)
- Ophthalmology (592)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1122)
- Primary Care Research (458)
- Public and Global Health (6557)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (187)
- Urology (167)